Annabel Samimy
Stock Analyst at Stifel
(3.37)
# 890
Out of 4,829 analysts
56
Total ratings
41.67%
Success rate
26.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Annabel Samimy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Initiates: Buy | $143 | $104.48 | +36.87% | 1 | Apr 10, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $22.77 | +97.63% | 1 | Mar 26, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $50 | $25.57 | +95.54% | 1 | Jan 8, 2025 | |
| ALT Altimmune | Initiates: Buy | $18 | $5.59 | +222.00% | 1 | Jan 8, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $17 | $3.62 | +369.61% | 4 | Nov 22, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $40 | $11.11 | +260.04% | 1 | Oct 8, 2024 | |
| KMDA Kamada | Initiates: Buy | $18 | $6.88 | +161.63% | 1 | Jul 3, 2024 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $24 | $3.14 | +664.33% | 1 | May 3, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $40 | $7.52 | +431.91% | 2 | Apr 12, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $80 | $27.55 | +190.38% | 6 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $230 | $97.78 | +135.22% | 8 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $25 | $9.80 | +155.10% | 1 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $18.58 | +88.37% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $65 | $17.30 | +275.72% | 3 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $28 → $11 | $0.31 | +3,471.43% | 4 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $14.60 | +208.22% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $0.86 | +831.53% | 1 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.73 | +3,187.67% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $20 | $29.34 | -31.83% | 1 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $750 | $1.46 | +51,269.86% | 3 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $24 | $31.70 | -24.29% | 7 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $21 | $0.73 | +2,776.71% | 6 | Sep 18, 2019 |
Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $104.48
Upside: +36.87%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $22.77
Upside: +97.63%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $25.57
Upside: +95.54%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $5.59
Upside: +222.00%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20 → $17
Current: $3.62
Upside: +369.61%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $11.11
Upside: +260.04%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $6.88
Upside: +161.63%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $3.14
Upside: +664.33%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $7.52
Upside: +431.91%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $27.55
Upside: +190.38%
Mar 15, 2024
Maintains: Buy
Price Target: $225 → $230
Current: $97.78
Upside: +135.22%
Mar 8, 2024
Reiterates: Buy
Price Target: $23 → $25
Current: $9.80
Upside: +155.10%
Oct 5, 2023
Initiates: Buy
Price Target: $35
Current: $18.58
Upside: +88.37%
Aug 29, 2023
Maintains: Buy
Price Target: $60 → $65
Current: $17.30
Upside: +275.72%
Jun 26, 2023
Downgrades: Hold
Price Target: $28 → $11
Current: $0.31
Upside: +3,471.43%
Mar 7, 2023
Initiates: Buy
Price Target: $45
Current: $14.60
Upside: +208.22%
Nov 10, 2022
Upgrades: Buy
Price Target: $8
Current: $0.86
Upside: +831.53%
Aug 24, 2021
Initiates: Buy
Price Target: $24
Current: $0.73
Upside: +3,187.67%
Apr 24, 2020
Initiates: Hold
Price Target: $20
Current: $29.34
Upside: -31.83%
Apr 16, 2020
Maintains: Buy
Price Target: $700 → $750
Current: $1.46
Upside: +51,269.86%
Apr 16, 2020
Maintains: Hold
Price Target: $25 → $24
Current: $31.70
Upside: -24.29%
Sep 18, 2019
Maintains: Hold
Price Target: $15 → $21
Current: $0.73
Upside: +2,776.71%